 BUFFALO, N.Y., Aug. 05, 2021 GLOBE NEWSWIRE -- 22nd Century Group, Inc. NYSE American: XXII, a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hempcannabis research, announced today that its common stock has been approved for uplisting to the Nasdaq Capital Market effective as of the market open on August 16, 2021. The shares will continue to trade under the ticker symbol XXII. 